Relapse during ongoing JAK inhibitor therapy is not uncommon in real-world alopecia areata management, and rescue outcomes are heterogeneous and not reliably predicted by baseline clinical features or the selected rescue approach, supporting individualized management.

Relapse of Alopecia Areata During Ongoing JAK Inhibitor Therapy Is Not Uncommon and Usually Occurs in Previously Affected Areas: A Multicentre Italian Real-World Study / A. Sechi, L.R.. - In: JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. - ISSN 0190-9622. - (2026). [Epub ahead of print] [10.1016/j.jaad.2026.08.031]

Relapse of Alopecia Areata During Ongoing JAK Inhibitor Therapy Is Not Uncommon and Usually Occurs in Previously Affected Areas: A Multicentre Italian Real-World Study

L. Valtellini
;
F. Bruni;M. Barbareschi;A.V. Marzano;
2026

Abstract

Relapse during ongoing JAK inhibitor therapy is not uncommon in real-world alopecia areata management, and rescue outcomes are heterogeneous and not reliably predicted by baseline clinical features or the selected rescue approach, supporting individualized management.
JAK inhibitors; alopecia areata; baricitinib; relapse; ritlecitinib
Settore MEDS-10/C - Malattie cutanee e veneree
2026
13-ago-2026
Article (author)
File in questo prodotto:
File Dimensione Formato  
PIIS0190962226033128.pdf

accesso aperto

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Licenza: Creative commons
Dimensione 869.21 kB
Formato Adobe PDF
869.21 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1267478
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex 0
social impact